Breaks Categories: News

ThursdayOct 20, 2016 12:19 pm

xG Technology, Inc. (XGTI) Inks Binding Agreement to Acquire Vislink Communication Systems

xG Technology (NASDAQ: XGTI, XGTIW), a provider of critical wireless communications for use in challenging operating environments, this morning announced its binding agreement to acquire the assets of the Vislink Communication Systems division from Hungerford, United Kingdom-based Vislink, Plc. The deal is expected to close by year-end 2016. "We believe that Vislink chose to sell the division to a purchaser that would operate the business as a going concern, versus financial acquirers.  We further believe that the combined business will create a market leader in video technology providing scale and global reach.  Considering the inherent synergies with our business unit Integrated…

Continue Reading

WednesdayOct 19, 2016 12:30 pm

Ballard Power Systems (BLDP) Commissions Second Tranche of Fuel Cell Buses in China

Ballard Power Systems (NASDAQ: BLDP; TSX: BLD) this morning announced the commissioning and deployment of 10 fuel cell-powered buses in the City of Yunfu, in the Province of Guangdong, China, bringing the total number of buses deployed to 22 of the 300 planned to be deployed in the Cities of Foshan and Yunfu. The initiative is part of the Chinese Government's plan to address air quality in urban centers through zero tailpipe emission mass transit solutions. To view the full press release, visit: http://nnw.fm/ooZV1 About Ballard Power Systems Ballard Power Systems (NASDAQ: BLDP; TSX: BLD) provides clean energy products that…

Continue Reading

WednesdayOct 19, 2016 12:29 pm

Marinus Pharmaceuticals, Inc. (MRNS) Shares Spike as Phase 1 Results for Ganaxolone Pave Way for Phase 2 Study

Marinus Pharmaceuticals (NASDAQ: MRNS) is trading more than 6% higher this morning after the company announced favorable results from its phase 1 dose-escalation study in which ganaxolone intravenous (IV) achieved dose levels targeted for efficacy in patients with status epilepticus (SE) – a life-threatening medical emergency associated with high mortality and limited treatments - and other indications. The phase 1 clinical study enrolled 36 subjects at Duke University Medical Center and was designed to determine the pharmacokinetics (PK), pharmacodynamics (PD), and safety of ganaxolone IV administered as an ascending bolus dose (Stage 1) or continuous infusion (Stage 2). Marinus is…

Continue Reading

TuesdayOct 18, 2016 1:34 pm

Life Clips, Inc. (LCLP) Shares Soar on Licensing Agreement with Hewlett Packard (HPE)

Shares of Life Clips (OTCQB: LCLP) are up 50% in mid-morning trade following the company’s announcement that it has entered into a multi-year license agreement to manufacture and distribute Hewlett Packard (NYSE: HPE) branded action cameras, still cameras, dash cameras and accessories in the United States, Canada, Europe, Africa, Latin America, Australia, New Zealand and Israel. The license agreement also calls for the development of a collaborative media cloud storage service platform to store content created by the HP branded products. To view the full press release, visit: http://nnw.fm/5Yx44 About Life Clips®, Inc: Life Clips is a developer and manufacturer…

Continue Reading

TuesdayOct 18, 2016 1:33 pm

Capstone Turbine Corporation (CPST) Prices $7.5M Offering

Capstone Turbine (NASDAQ: CPST) this morning announced a registered offering in which it will sell 6.3 million shares of its common stock to one existing and one new accredited investor at a price of $1.20 per share. The gross proceeds from the offering are expected to be approximately $7.5 million. Capstone said it intends to use the proceeds from the offering to fund general working capital requirements and for other general corporate purposes. The offering is expected to close on or about October 21, 2016, subject to the satisfaction of customary closing conditions. To view the full press releases, visit:…

Continue Reading

MondayOct 17, 2016 1:24 pm

RLJ Entertainment (RLJE), AMC Networks (AMCX) Enter into Strategic Partnership – Shares of Both Companies Higher

RLJ Entertainment (NASDAQ: RLJE) this morning announced its strategic partnership with AMC Networks (NASDAQ: AMCX) under which AMC Networks has invested $65 million – in the form of loans - to RLJ Entertainment to provide capital and additional resources needed to explore growth opportunities. Additionally, AMC Networks has received warrants which potentially provides the company at least 50.1% of the outstanding RLJ Entertainment common stock on a fully diluted basis. To view the full press release, visit: http://nnw.fm/hQ7sB About RLJ Entertainment RLJ Entertainment, Inc. (NASDAQ: RLJE) is an entertainment content distribution company in primarily North America, the United Kingdom, and…

Continue Reading

MondayOct 17, 2016 1:21 pm

MagneGas Corporation (MNGA) Signs LOI for $2.65M Sale of Certain Equipment and Supplies

MagneGas (NASDAQ: MNGA) is trading higher this morning after the technology company announced its Letter of Intent ("LOI") to manufacture and deliver certain equipment and supplies to an undisclosed company based in Germany, marking its largest equipment sale to-date. MagneGas will receive $2.65 million for its proprietary Gasification and Sterilization systems and will supply MagnesGas2® fuel and cylinders. The Gasification system will be used to produce MagneGas2® fuel to sell into the German market with the potential of other markets coming online soon after. The Sterilization system will be used for demonstrations and small service contracts with the goal of…

Continue Reading

MondayOct 17, 2016 1:20 pm

ContraVir Pharmaceuticals, Inc. (CTRV) Shares Spike on Positive Safety Profile of CMX157

Shares of ContraVir Pharmaceuticals (NASDAQ: CTRV) are trading more than 28% higher in late morning trade after the company said it will pivot from a positive recommendation from an independent Data Safety Monitoring Board (DSMB) to begin enrollment of the next dosing group in its head-to-head phase 2a dose-escalation study. The study is structured to compare the safety and efficacy of ContraVir's CMX157 to tenofovir disoproxil fumarate (TDF, marketed by Gilead Sciences as Viread®) in patients with chronic hepatitis B (HBV). ContraVir expects to complete the remaining two escalation cohorts and report top-line results by year-end 2016. To view the…

Continue Reading

MondayOct 17, 2016 1:17 pm

eXp World Holdings, Inc. (EXPI) Expands Brokerage with Industry Leaders

eXp Realty, LLC, a subsidiary of eXpWorld Holdings, Inc. (OTCQB: EXPI), this morning announced that the Brent Gove team, one of leading real estate teams in California, has joined its growing national real estate brokerage company. Among other achievements, Gove previously served as CEO and Team Leader of the Roseville, California, market center for Keller Williams Realty, which was the most profitable market center in the nation during his tenure for Q1 2010; he is also co-author of the book "Top Dollar," which achieved Amazon.com bestseller status in two categories. eXp also recently welcomed Miguel Herrera, the top-rated international luxury…

Continue Reading

FridayOct 14, 2016 3:49 pm

Tetraphase Pharmaceuticals, Inc. (TTPH) Doses First Patient in IGNITE4 Clinical Trial

Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) this morning announced that it has dosed the first patient in IGNITE4, the company’s phase 3 clinical trial evaluating the efficacy and safety of intravenous (IV) eravacycline compared to meropenem in complicated intra-abdominal infections (cIAI).  Eravacycline is a novel antibiotic candidate with potent activity against multidrug-resistant (MDR) pathogens for the treatment of serious and life-threatening bacterial infections. To view the full press release, visit:  http://nnw.fm/RFg2j About Tetraphase Pharmaceuticals, Inc. Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections, including those caused by many…

Continue Reading